Search Results - "Katz, David E"

Refine Results
  1. 1

    The Continuing Plague of Extended-spectrum β-lactamase–producing Enterobacteriaceae Infections by Adler, Amos, MD, Katz, David E., MD, MPH, Marchaim, Dror, MD

    “…Antimicrobial resistance is a common iatrogenic complication of modern life and medical care. One of the most demonstrative examples is the exponential…”
    Get full text
    Journal Article
  2. 2

    Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii Infections by Tal-Jasper, Ruthy, Katz, David E, Amrami, Nadav, Ravid, Dor, Avivi, Dori, Zaidenstein, Ronit, Lazarovitch, Tsilia, Dadon, Mor, Kaye, Keith S, Marchaim, Dror

    Published in Antimicrobial agents and chemotherapy (01-05-2016)
    “…Carbapenems are considered the treatment of choice for Acinetobacter baumannii infections. Many facilities implement preventive measures toward only…”
    Get full text
    Journal Article
  3. 3

    Using the Elixhauser risk adjustment model to predict outcomes among patients hospitalized in internal medicine at a large, tertiary-care hospital in Israel by Katz, David E, Leibner, Gideon, Esayag, Yaakov, Kaufman, Nechama, Brammli-Greenberg, Shuli, Rose, Adam J

    Published in Israel journal of health policy research (01-11-2023)
    “…Background In Israel, internal medicine admissions are currently reimbursed without accounting for patient complexity. This is at odds with most other…”
    Get full text
    Journal Article
  4. 4

    Mixed effect of increasing outflow of medical patients from an emergency department by Mendlovic, Joseph, Zalut, Todd, Munter, Gabriel, Merin, Ofer, Yinnon, Amos M, Katz, David E

    Published in Israel journal of health policy research (27-10-2021)
    “…Since 2014, the annual number of patients entering our emergency department (ED) has increased significantly. These were primarily Internal Medicine (IM)…”
    Get full text
    Journal Article
  5. 5

    The impact of improper empirical usage of antipseudomonals on admission to an acute care hospital by Kronenfeld, Nirit, Zilberman-Itskovich, Shani, Lazarovitch, Tsillia, Zaidenstein, Ronit, Saadon, Hodaya, Maya, Tal, Katz, David E., Marchaim, Dror

    “…•Among 1536 consecutive patients with sepsis on admission, 192 patients (13%) received empirical antipseudomonals for their suspected infection.•Only 3.7% of…”
    Get full text
    Journal Article
  6. 6

    Diabetic foot infection in hospitalized adults by Katz, David E, Friedman, N. Deborah, Ostrovski, Evgenia, Ravid, Dor, Amrami, Nadav, Avivi, Dori, Mengesha, Bethlehem, Zaidenstein, Ronit, Lazarovitch, Tsilia, Dadon, Mor, Marchaim, Dror

    “…Abstract Background Acute infections of the diabetic foot (DFI) are a common and complex condition. Patients are generally managed in the ambulatory setting…”
    Get full text
    Journal Article
  7. 7

    The Continuing Plague of Extended-Spectrum β-Lactamase Producing Enterbacterales Infections: An Update by Adler, Amos, Katz, David E, Marchaim, Dror

    “…Antimicrobial resistance is a common iatrogenic complication of modern life and medical care. One of the most demonstrative examples is the exponential…”
    Get full text
    Journal Article
  8. 8

    Escherichia coli, cattle and the propagation of disease by Stein, Richard A, Katz, David E

    Published in FEMS microbiology letters (01-03-2017)
    “…Several early models describing host-pathogen interaction have assumed that each individual host has approximately the same likelihood of becoming infected or…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Chloramphenicol treatment revisited – demographics, clinical characteristics, and outcomes of hospitalized patients by Ben-Chetrit, Eli, Bnaya, Alon, Barchad, Orit Wolfovitz, Vedder, Koral, Katz, David E.

    “…Limited literature exists on chloramphenicol’s clinical use. In this retrospective, single-center case-series, we examined 183 chloramphenicol-treated and 81…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Community-Based Safety, Immunogenicity, and Transmissibility Study of the Shigella sonnei WRSS1 Vaccine in Israeli Volunteers by Orr, Nadav, Katz, David E, Atsmon, Jacob, Radu, Paull, Yavzori, Miri, Halperin, Tamar, Sela, Tamar, Kayouf, Raid, Klein, Zivit, Ambar, Ruhama, Cohen, Dani, Wolf, Marcia K, Venkatesan, Malabi M, Hale, Thomas L

    Published in Infection and Immunity (01-12-2005)
    “…We describe the first community-based evaluation of Shigella sonnei strain WRSS1, a live, oral candidate vaccine attenuated by a 212-bp deletion in the virG…”
    Get full text
    Journal Article
  13. 13

    Internal medicine patients admitted without COVID-19 during the outbreak by Mendlovic, Joseph, Weiss, Gali, Da'as, Nael, Yinnon, Amos, Katz, David E

    “…The first case of COVID-19 in Israel was reported on February 21, 2020. Shaare Zedek (SZ), a 1000-bed tertiary care medical centre in Jerusalem, Israel, cared…”
    Get more information
    Journal Article
  14. 14

    Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia by Ben-Chetrit, Eli, Eldaim, Mustafa Abed, Bar-Meir, Maskit, Dodin, Mutaz, Katz, David E.

    “…•ESBL-positive bacteremia were associated with CVC, hospital exposure, and exposure to antimicrobial therapy within the previous 6 months.•Neutropenic patients…”
    Get full text
    Journal Article
  15. 15

    Colistin-resistant Klebsiella pneumoniae bloodstream infection: old drug, bad bug by Ben-Chetrit, Eli, Mc Gann, Patrick, Maybank, Rosslyn, Stam, Jason, Assous, Marc V., Katz, David E.

    Published in Archives of microbiology (01-08-2021)
    “…Multi-drug-resistant (MDR)  Enterobacteriaceae  pose a global threat to hospitalized patients. We report a series of colistin-resistant  Klebsiella pneumoniae…”
    Get full text
    Journal Article
  16. 16

    The epidemiology of carbapenem resistant Enterobacter spp: A case–case–control matched analysis by Cohen Mendel, Leore, Amity, Keren, Katz, David E., Lazarovitch, Tsilia, Zaidenstein, Ronit, Marchaim, Dror

    “…A case–case–control investigation (216 patients) examined the risk factors and outcomes of carbapenem-resistant Enterobacter (CR-En) acquisition. Recent…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Phase I Evaluation of ΔvirG Shigella sonnei Live, Attenuated, Oral Vaccine Strain WRSS1 in Healthy Adults by KOTLOFF, Karen L, TAYLOR, David N, CAMPBELL, James D, LEVINE, Myron M, HALE, Thomas L, SZTEIN, Marcelo B, WASSERMAN, Steven S, LOSONSKY, Genevieve A, NATARO, James P, VENKATESAN, Malabi, HARTMAN, Antoinette, PICKING, William D, KATZ, David E

    Published in Infection and Immunity (01-04-2002)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  19. 19

    Antimicrobial use for asymptomatic bacteriuria-First, do no harm by Shpunt, Yana, Estrin, Inna, Levi, Yossef, Saadon, Hodaya, Ben-Yossef, Galit, Goldshtein, Lili, Klafter, Dan, Zilberman-Itskovich, Shani, Ben-David, Debby, Katz, David E, Lazarovitch, Tsillia, Zaidenstein, Ronit, Marchaim, Dror

    “…Administration of antimicrobials to patients with asymptomatic bacteriuria (ASB) is a common error that can lead to worse outcomes. However, controlled…”
    Get full text
    Journal Article
  20. 20

    Maximizing the Role of Emergency Medical Services in COVID-19 Response by Sonkin, Roman, Alpert, Evan Avraham, Katz, David E, Jaffe, Eli

    “…The Centers for Disease Control and Prevention define 6 intervals of a pandemic: (1) investigation of cases, (2) recognition of the increased potential for…”
    Get more information
    Journal Article